The renin-angiotensin-aldosterone system (RAAS) plays pivotal roles in the pathogenesis of chronic kidney disease (CKD) progression and its increased complications such as hypertension (HT) and cardiovascular diseases (CVD). Previous studies suggested that aliskiren a direct renin inhibitor, blocks RAAS and may be effective for the management of CKD and its complications. This review focuses on the effects of aliskiren on CKD. © 2013, Kowsar Corp.; Published by Kowsar Corp.
CITATION STYLE
Morishita, Y., & Kusano, E. (2013). Direct renin inhibitor: Aliskiren in chronic kidney disease. Nephro-Urology Monthly. Brieflands. https://doi.org/10.5812/numonthly.3679
Mendeley helps you to discover research relevant for your work.